logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Taraneh Ghaffari Farazi

This inventor holds 102 USPTO granted patents and 15 published patent applications and 1 EPO patent, primarily in Cardiac Monitoring (CPC class A61B5-0452). Top assignee: Pacesetter, Inc.. Active years: 2006-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taraneh Ghaffari Farazi. Retrieved from https://idiyas.com/inventor/taraneh-ghaffari-farazi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 102 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.2

ph-index = 19

Forward Citations = 1,650(Granted Patents)

Forward Citations (Not Self Cited) = 1,569(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Santa Clara, CA (US) (2012 - 2015)
  • San Jose, CA (US) (2006 - 2021)

Company Filing History:

goldMedal102 out of 2,450 
 
Pacesetter, Inc.
 patents

Years Active: 2006-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Cardiac Stimulation
Atrial Fibrillation
Tachycardia
Myocardial Stability
Erythropoeitin Production
Bioelectric Battery
Neurostimulation
Implantable Devices
Blood Pressure Monitoring
Electrical Stimulation
Ischemic Events
Diastolic Function
102 patents (USPTO):Explore Patents
1. 10888701 - Implantable cardiac stimulation device and method that stabilizes ventricular rate during episodes of atrial fibrillation (2021-01-12),
2. 10322290 - Systems and methods for integrating temporary induced dyssynchrony therapy with cardiac resynchronization therapy (2019-06-18),
3. 10201705 - Erythropoeitin production by electrical stimulation (2019-02-12),
4. 10179243 - Systems and methods for providing temporary induced dyssynchrony therapy to patients with atrial tachycardia (2019-01-15),
5. 10166397 - Systems and methods for intermittent multipoint pacing (2019-01-01),
6. 10065040 - Method to stabilize ventricular rate during episodes of atrial fibrillation (2018-09-04),
7. 9687656 - Arterial blood pressure monitoring devices, systems and methods for use while pacing (2017-06-27),
8. 9610444 - Erythropoeitin production by electrical stimulation (2017-04-04),
9. 9295844 - Bioelectric battery for implantable device applications (2016-03-29),
10. 9282895 - Method and implantable system for blood-glucose concentration monitoring using parallel methodologies (2016-03-15),
11. 9205274 - Devices, systems, and methods for characterizing a tachycardia and/or selecting treatment for a tachycardia using results of a dominant frequency analysis (2015-12-08),
12. 9174054 - Monitoring heart disease using implantable sensors (2015-11-03),
13. 9162067 - Methods and devices for monitoring myocardial electro-mechanical stability (2015-10-20),
14. 9162065 - Systems and methods for estimating central arterial blood pressure of a patient (2015-10-20),
15. 9149199 - Method and apparatus for monitoring arrythmogenic effects of medications using an implantable device (2015-10-06),

Title: Spotlight on Taraneh Ghaffari Farazi: A Pioneer in Cardiac Innovation

Introduction: Taraneh Ghaffari Farazi, based in San Jose, CA, is a prolific inventor with an impressive portfolio comprising 102 patents. His innovative work focuses on cardiac devices, making significant contributions to the field of medical technology. In this article, we delve into his latest patents, career highlights, and collaborations.

Latest Patents: Farazi's latest patents showcase his expertise in cardiac stimulation devices. One of his notable inventions is the "Implantable Cardiac Stimulation Device and Method That Stabilizes Ventricular Rate During Episodes of Atrial Fibrillation." This device provides electrical stimulation therapy designed to stabilize the ventricular rate during atrial fibrillation episodes by delivering sub-threshold stimulation pulses. Another significant patent is for "Systems and Methods for Integrating Temporary Induced Dyssynchrony Therapy with Cardiac Resynchronization Therapy." This innovation integrates cardiac resynchronization therapy with temporary induced dyssynchrony therapy to improve patient outcomes through advanced implantable devices.

Career Highlights: Taraneh Ghaffari Farazi has played a vital role at Pacesetter, Inc., where he has brought forth groundbreaking advancements in cardiac technology. His work emphasizes enhanced patient care and innovative solutions for managing cardiovascular conditions.

Collaborations: Throughout his career, Farazi has collaborated with esteemed colleagues such as Gene A. Bornzin and Brian Jeffrey Wenzel. These partnerships have fostered an environment of innovation, allowing for the development of cutting-edge products that address critical health challenges.

Conclusion: Taraneh Ghaffari Farazi stands out as a leading inventor in the medical device industry, particularly in cardiac health. His extensive patent portfolio and dedication to advancing technology reflect his commitment to improving patient outcomes and revolutionizing cardiovascular care. As he continues to innovate, the impact of his work will undoubtedly resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…